Human trial / 2021
Phase 1 study of recombinant human thymosin beta-4
Phase 1 study of recombinant human thymosin beta-4 — PubMed (2021), cited in PeptideAgent's Thymosin Beta-4 evidence record.
Open original sourceSOURCE METADATA
What this record represents.
- Publisher
- PubMed
- Evidence type
- Human trial
- Publication year
- 2021
- Source ID
- pmid-34346165
WHERE THIS IS CITED